BR9407397A - Hydrogel microencapsulated vaccines - Google Patents
Hydrogel microencapsulated vaccinesInfo
- Publication number
- BR9407397A BR9407397A BR9407397A BR9407397A BR9407397A BR 9407397 A BR9407397 A BR 9407397A BR 9407397 A BR9407397 A BR 9407397A BR 9407397 A BR9407397 A BR 9407397A BR 9407397 A BR9407397 A BR 9407397A
- Authority
- BR
- Brazil
- Prior art keywords
- hydrogel
- microencapsulated
- vaccines
- microencapsulated vaccines
- hydrogel microencapsulated
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G79/00—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule
- C08G79/02—Macromolecular compounds obtained by reactions forming a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbon with or without the latter elements in the main chain of the macromolecule a linkage containing phosphorus
- C08G79/025—Polyphosphazenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/090,841 US5562909A (en) | 1993-07-12 | 1993-07-12 | Phosphazene polyelectrolytes as immunoadjuvants |
US08/147,781 US5529777A (en) | 1993-07-12 | 1993-11-04 | Hydrogel microencapsulated vaccines |
PCT/US1994/007749 WO1995002416A1 (en) | 1993-07-12 | 1994-07-11 | Hydrogel microencapsulated vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9407397A true BR9407397A (en) | 1996-11-05 |
Family
ID=26782696
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9407397A BR9407397A (en) | 1993-07-12 | 1994-07-11 | Hydrogel microencapsulated vaccines |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0792161A4 (en) |
JP (1) | JPH09500132A (en) |
CN (1) | CN1128953A (en) |
AU (1) | AU690567B2 (en) |
BR (1) | BR9407397A (en) |
CA (1) | CA2167081A1 (en) |
NZ (1) | NZ269411A (en) |
WO (1) | WO1995002416A1 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPM572294A0 (en) * | 1994-05-18 | 1994-06-09 | Vaccine Technologies Pty. Ltd. | Delivery vehicle for bioactive molecule |
US5674495A (en) * | 1995-02-27 | 1997-10-07 | Purdue Research Foundation | Alginate-based vaccine compositions |
US5879712A (en) * | 1995-06-07 | 1999-03-09 | Sri International | Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced |
US5807757A (en) * | 1996-07-02 | 1998-09-15 | Virus Research Institute, Inc. | Preparation of ionically cross-linked polyphosphazene microspheresy by coacervation |
US5980948A (en) * | 1996-08-16 | 1999-11-09 | Osteotech, Inc. | Polyetherester copolymers as drug delivery matrices |
AU7563798A (en) * | 1997-04-30 | 1998-11-24 | Emory University | Methods and compositions for administering dna to mucosal surfaces |
AU751182B2 (en) * | 1997-12-02 | 2002-08-08 | Archimedes Development Limited | Compositions for nasal administration |
US7087236B1 (en) | 1998-09-01 | 2006-08-08 | Merrion Research I Limited | Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
EP1280521B1 (en) | 2000-05-12 | 2005-07-20 | Pharmacia & Upjohn Company LLC | Vaccine composition, method of preparing the same, and method of vaccinating vertebrates |
US20040131631A1 (en) * | 2002-11-22 | 2004-07-08 | Alexander Andrianov | Polyphosphazene immunostimulants |
GB0300531D0 (en) | 2003-01-10 | 2003-02-12 | West Pharm Serv Drug Res Ltd | Pharmaceutical compositions |
CA2513483C (en) | 2003-01-17 | 2011-11-29 | Cornell Research Foundation, Inc. | Injectable hydrogel microspheres from aqueous two-phase system |
ES2360542T3 (en) * | 2004-10-25 | 2011-06-06 | Celonova Biosciences Germany Gmbh | LOADABLE POLYMER PARTICLES FOR THERAPEUTIC APPLICATIONS AND / OR DIAGNOSTICS AND PROCEDURES TO PREPARE AND USE THE SAME. |
KR100784485B1 (en) | 2006-01-18 | 2007-12-11 | 한국과학기술연구원 | Biodegradable and thermosensitive polyorganophosphazene hydrogel, preparation method thereof and use thereof |
WO2008100142A2 (en) * | 2007-02-12 | 2008-08-21 | Octoplus Sciences B.V. | Vaccine formulation |
EP1985284A1 (en) * | 2007-04-25 | 2008-10-29 | OctoPlus Sciences B.V. | Vaccine formulation |
EP2196196A1 (en) * | 2008-12-10 | 2010-06-16 | Medipol S.A. | Compound, medicament, vaccine composition and nanocapsules |
US8883717B2 (en) * | 2012-03-30 | 2014-11-11 | Artificial Cell Technologies, Inc. | Antigenic compositions and methods |
GB201212010D0 (en) * | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
AU2014357580B2 (en) | 2013-12-06 | 2019-08-01 | Intervet International Bv | Composition for oral delivery of bioactive agents |
EP3368609A4 (en) * | 2015-10-28 | 2019-07-24 | University of Maryland, College Park | Multifunctional biodegradable carriers for drug delivery |
CN105214100A (en) * | 2015-11-16 | 2016-01-06 | 中国医学科学院生物医学工程研究所 | A kind of pH response microcapsule-type protein vaccine carrier and preparation method |
CN112618709B (en) * | 2019-09-24 | 2023-11-03 | 华南理工大学 | Pig oral vaccination slow-release adjuvant and preparation method and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4880622A (en) * | 1986-05-20 | 1989-11-14 | Research Corporation Technologies, Inc. | Water-soluble phosphazene polymers having pharmacological applications |
GB8826116D0 (en) * | 1988-11-08 | 1988-12-14 | Danbiosyst Ltd | Adhesive drug delivery composition |
US5032405A (en) * | 1989-09-27 | 1991-07-16 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
US5149543A (en) * | 1990-10-05 | 1992-09-22 | Massachusetts Institute Of Technology | Ionically cross-linked polymeric microcapsules |
-
1994
- 1994-07-11 AU AU73286/94A patent/AU690567B2/en not_active Ceased
- 1994-07-11 WO PCT/US1994/007749 patent/WO1995002416A1/en not_active Application Discontinuation
- 1994-07-11 CN CN94193066A patent/CN1128953A/en active Pending
- 1994-07-11 JP JP7504650A patent/JPH09500132A/en not_active Ceased
- 1994-07-11 NZ NZ269411A patent/NZ269411A/en unknown
- 1994-07-11 EP EP94923417A patent/EP0792161A4/en not_active Withdrawn
- 1994-07-11 CA CA002167081A patent/CA2167081A1/en not_active Abandoned
- 1994-07-11 BR BR9407397A patent/BR9407397A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH09500132A (en) | 1997-01-07 |
CA2167081A1 (en) | 1995-01-26 |
WO1995002416A1 (en) | 1995-01-26 |
EP0792161A1 (en) | 1997-09-03 |
CN1128953A (en) | 1996-08-14 |
AU690567B2 (en) | 1998-04-30 |
EP0792161A4 (en) | 1998-04-29 |
NZ269411A (en) | 2001-03-30 |
AU7328694A (en) | 1995-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9407397A (en) | Hydrogel microencapsulated vaccines | |
DE69411221D1 (en) | Tri-carbamate functional crosslinker | |
DE69533227D1 (en) | REHYDRATED HYDROGEL | |
NO961757L (en) | Vacuumlöfte device | |
BR9404448A (en) | Together artuculate sphere | |
DE69431099D1 (en) | Pipette-washing device | |
NO933753D0 (en) | ROER-repair DEVICE | |
IT1261545B (en) | SINGULARIZER DEVICE | |
DE59308042D1 (en) | Ophthalmic device | |
FI92525B (en) | Ventilation-heating unit | |
DE69422018D1 (en) | INTERFACE DEVICE | |
DE69419620D1 (en) | FLUORATION PROCEDURE | |
DE69427178D1 (en) | Modulators | |
FI930227A0 (en) | Suspension device | |
DE69409729D1 (en) | HELICOPTER | |
FI941763A (en) | Skin | |
KR950012854U (en) | Thermostat | |
KR950010962U (en) | Tee-up device | |
DE69409920D1 (en) | Attached device | |
KR950005513U (en) | Function device | |
KR940026468U (en) | Human Resources | |
KR950016466U (en) | Handout | |
KR950002748U (en) | Hook | |
KR940020160U (en) | Warming | |
SE9303844D0 (en) | Suspension device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) | ||
FC | Decision: refusal | ||
TC | Change of name | ||
ND | Extension of time allowed | ||
CKFC | Appeal: appeal against refusal |